By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    first aid guide
    A Deep Dive into First Aid and CPR Certification
    February 19, 2024
    back pain
    No More Aches! A Guide To Effective Back Pain Relief
    March 28, 2024
    workplace first aid
    First Aid Training Can Improve Workplace Health & Safety
    June 27, 2024
    Latest News
    Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
    July 20, 2025
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    healthcare literacy
    Are You Health Literate?
    July 4, 2012
    Patient Power in Indiana
    December 9, 2011
    2/365 teenage pregnancy
    Make IUDs and Implants More Affordable and Accessible for Teens
    September 25, 2012
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Alzheimer’s Slowed by Omega-3 Supplements?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > News > Alzheimer’s Slowed by Omega-3 Supplements?
NewsSpecialties

Alzheimer’s Slowed by Omega-3 Supplements?

Susan Scutti
Susan Scutti
Share
5 Min Read
Alzheimer's and fatty acids
SHARE
In patients with Alzheimer’s disease, previous research has observed lower than normal concentrations of docosahexaenoic acid (DHA), an omega-3 fatty acid, in the brain. In research published in the Journal of Internal Medicine, a team of Swedish scientists prove omega-3 fatty acids can cross the blood brain barrier, where they affect a well-known biomarker for Alzheimer’s disease as well as an indicator of inflammation.
“In animals, DHA dietary supplements can lead to an increase in DHA concentrations in the [central nervous system]. Here we show that the same applies to humans, which suggests that omega-3 fatty acids in dietary supplements cross the blood-brain barrier,” Professor Jan Palmblad stated in a press release. “However, much work remains to be done before we know how these fatty acids can be used in the treatment of Alzheimer’s disease to halt memory loss.”

Natural Barrier

Omega-3 fatty acids are essential nutrients for many bodily functions, including control of blood clotting and building cell membranes in the brain. During gestation, omega-3 and other essential polyunsaturated fatty acids accumulate in the central nervous system. Scientists assume that these acids are continually replaced throughout our lives, but little is known about how this occurs since our bodies do not make omega-3 fats. Because we do obtain these fats through food, scientists speculate that important fatty acids routinely cross the blood-brain barrier, which serves to protect the brain from harmful chemicals, including those that naturally in the blood yet also other ingested substances. In the current study, conducted at the Karolinska Institutet in Stockholm, researchers worked with Alzheimer’s patients who were participants in a study in which they received DHA or a placebo daily for half a year. Additionally, 33 of these patients were divided into two groups with one receiving an omega-3 supplement and the other receiving only a placebo. The researchers wanted to see whether omega-3 dietary supplements might change the fatty acid profile of the central nervous system in patients with mild Alzheimer’s disease. At the end of the study period, the researchers discovered that those in the omega-3 supplement group displayed significant increases in eicosapentaenoic acid (commonly known as EPA, another omega-3 fatty acid), DHA, and total omega-3 fatty acid levels in both the cerebrospinal fluid (which surrounds the central nervous system) and blood, whereas the placebo group showed no changes. In contrast to DHA, changes in levels of EPA and docosapentaenoic acid (sometimes called DPA, another omega-3 fatty acid) in cerebrospinal fluid and blood were strongly correlated. The scientists also observed that increasing DHA levels in cerebrospinal fluid was related to lower levels of total and phosphorylated tau in the cerebrospinal fluid — a biomarker of Alzheimer’s disease. Plus, higher levers of DHA were also associated with higher levels of soluble interleukin-1 receptor type II, which is a biomarker for inflammation. In other words, the more DHA was seen to increase in the cerebrospinal fluid, the greater its effect on both Alzheimer’s disease and inflammation. Because oral supplements conferred changes in the omega-3 fatty acid profile in the cerebrospinal fluid of participants, the researchers concluded that this would suggest transfer of these fatty acids across the blood brain barrier in adults. “Earlier population studies indicate that omega-3 can protect against Alzheimer’s disease, which makes it interesting to study the effects of dietary supplements containing this group of fatty acids in patients who have already developed the disease,” the study’s lead author Dr. Yvonnne Freund-Levi said.   Source: Freund-Levi Y, Palmblad J, Vedin I, et al. Transfer of omega-3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid (DHA)-rich omega-3 fatty acid preparation in patients with Alzheimer’s disease: the OmegAD study. Journal of Internal Medicine. 2013. (shutterstock)

TAGGED:Alzheimersomega-3 supplements
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

botox certification
Help Improve People’s Skin Health Via Botox Certification
Skin Specialties
July 22, 2025
Telemedicine Apps
Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
Health
July 20, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025

You Might also Like

dementia care
NewsWellness

When is it Time to Seek Professional Support for a Relative With Dementia?

May 24, 2022

Caremerge Nudges Long-Term Care Coordination Into the Mobile Health Era

July 13, 2013

Healthcare Market Consolidation is Shaped By Consumerism

February 1, 2013

Ripping Off Medicare

November 23, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?